화학공학소재연구정보센터
검색결과 : 14건
No. Article
1 B cells and tertiary lymphoid structures promote immunotherapy response
Helmink BA, Reddy SM, Gao JJ, Zhang SJ, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han GC, Gopalakrishnan V, Xi YX, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu WB, LeBleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, McBride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Sautes-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang LH, Wargo JA
Nature, 577(7791), 549, 2020
2 Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
Wellenstein MD, Coffelt SB, Duits DEM, van Miltenburg MH, Slagter M, de Rink I, Henneman L, Kas SM, Prekovic S, Hau CS, Vrijland K, Drenth AP, de Korte-Grimmerink R, Schut E, van der Heijden I, Zwart W, Wessels LFA, Schumacher TN, Jonkers J, de Visser KE
Nature, 572(7770), 538, 2019
3 Neoantigen landscape dynamics during human melanoma-T cell interactions
Verdegaal EME, de Miranda NFCC, Visser M, Harryvan T, van Buuren MM, Andersen RS, Hadrup SR, van der Minne CE, Schotte R, Spits H, Haanen JBAG, Kapiteijn EHW, Schumacher TN, van der Burg SH
Nature, 536(7614), 91, 2016
4 The "cancer immunogram"
Blank CU, Haanen JB, Ribas A, Schumacher TN
Science, 352(6286), 658, 2016
5 Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Stronen E, Toebes M, Kelderman S, van Buuren MM, Yang WW, van Rooij N, Donia M, Boschen ML, Lund-Johansen F, Olweus J, Schumacher TN
Science, 352(6291), 1337, 2016
6 Functional heterogeneity of human memory CD4(+) T cell clones primed by pathogens or vaccines
Becattini S, Latorre D, Mele F, Foglierini M, De Gregorio C, Cassotta A, Fernandez B, Kelderman S, Schumacher TN, Corti D, Lanzavecchia A, Sallusto F
Science, 347(6220), 400, 2015
7 Neoantigens in cancer immunotherapy
Schumacher TN, Schreiber RD
Science, 348(6230), 69, 2015
8 Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, Lee W, Yuan JD, Wong P, Ho TS, Miller ML, Rekhtman N, Moreira AL, Ibrahim F, Bruggeman C, Gasmi B, Zappasodi R, Maeda Y, Sander C, Garon EB, Merghoub T, Wolchok JD, Schumacher TN, Chan TA
Science, 348(6230), 124, 2015
9 Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin MM, Zhang XL, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, Mulder GE, Toebes M, Vesely MD, Lam SSK, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce EL, Schumacher TN, Aebersold R, Rammensee HG, Melief CJM, Mardis ER, Gillanders WE, Artyomov MN, Schreiber RD
Nature, 515(7528), 577, 2014
10 Skin-resident memory CD8(+) T cells trigger a state of tissue-wide pathogen alert
Ariotti S, Hogenbirk MA, Dijkgraaf FE, Visser LL, Hoekstra ME, Song JY, Jacobs H, Haanen JB, Schumacher TN
Science, 346(6205), 101, 2014